LI
PFE icon

LMCG Investments’s Pfizer PFE Stock Holding History

LMCG Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
43,942
+725
+2% +$19K 0.06% 167
2026
Q1 		$1.21M Buy
43,217
+5,800
+16% +$154K 0.07% 150
2025
Q4 		$932K Sell
37,417
-29,443
-44% -$742K 0.05% 161
2025
Q3 		$1.7M Buy
66,860
+4,263
+7% +$105K 0.1% 135
2025
Q2 		$1.52M Buy
62,597
+2,284
+4% +$53.3K 0.1% 143
2025
Q1 		$1.53M Buy
60,313
+4,339
+8% +$114K 0.1% 152
2024
Q4 		$1.48M Buy
55,974
+3,804
+7% +$103K 0.09% 148
2024
Q3 		$1.51M Buy
52,170
+393
+0.8% +$11.5K 0.09% 142
2024
Q2 		$1.45M Buy
51,777
+543
+1% +$14.9K 0.08% 150
2024
Q1 		$1.42M Buy
51,234
+10,049
+24% +$279K 0.08% 162
2023
Q4 		$1.19M Sell
41,185
-1,946
-5% -$58.8K 0.07% 206
2023
Q3 		$1.43M Sell
43,131
-478
-1% -$16.9K 0.1% 182
2023
Q2 		$1.6M Buy
43,609
+3,420
+9% +$133K 0.1% 175
2023
Q1 		$1.64M Sell
40,189
-227
-0.6% -$9.8K 0.11% 171
2022
Q4 		$2.07M Buy
40,416
+207
+0.5% +$9.92K 0.14% 149
2022
Q3 		$1.76M Sell
40,209
-339
-0.8% -$16.5K 0.13% 171
2022
Q2 		$2.13M Buy
40,548
+1,671
+4% +$85.2K 0.15% 149
2022
Q1 		$2.01M Buy
+38,877
New +$2.02M 0.12% 172
2015
Q3 		$9.67M Sell
324,595
-2,088
-0.6% -$66.9K 0.21% 189
2015
Q2 		$10.4M Sell
326,683
-5,823
-2% -$190K 0.22% 167
2015
Q1 		$11M Buy
332,506
+2,008
+0.6% +$63.8K 0.23% 179
2014
Q4 		$9.77M Buy
330,498
+3,369
+1% +$96.6K 0.21% 195
2014
Q3 		$9.18M Sell
327,129
-6,203
-2% -$174K 0.21% 210
2014
Q2 		$9.39M Sell
333,332
-4,123
-1% -$118K 0.2% 205
2014
Q1 		$10.3M Sell
337,455
-2,959
-0.9% -$88.2K 0.23% 191
2013
Q4 		$9.89M Sell
340,414
-2,729
-0.8% -$79.4K 0.21% 192
2013
Q3 		$9.35M Sell
343,143
-16,982
-5% -$462K 0.23% 166
2013
Q2 		$9.57M Buy
+360,125
New +$9.95M 0.25% 142

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LMCG Investments's PFE Position: Q2 2026 in Review

LMCG Investments increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $19K and bringing the position to 43,942 shares worth $1.06M. The position accounts for 0.06% of the portfolio, ranked #167.

LMCG Investments first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. The position peaked at $11M in Q1 2015. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • LMCG Investments held 43,942 shares of Pfizer worth $1.06M as of Q2 2026.
  • LMCG Investments bought 725 Pfizer shares in Q2 2026, an estimated $19K.
  • Pfizer made up 0.06% of LMCG Investments's portfolio in Q2 2026, its #167 holding.
  • LMCG Investments first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • LMCG Investments's Pfizer position peaked at $11M in Q1 2015.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.